Detalhe da pesquisa
1.
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells.
Ann Hematol
; 100(12): 2943-2956, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390367
2.
ToTem: a tool for variant calling pipeline optimization.
BMC Bioinformatics
; 19(1): 243, 2018 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940847
3.
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
Blood
; 127(3): 325-32, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423830
4.
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
Haematologica
; 98(7): 1124-31, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585524
5.
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN.
Cancers (Basel)
; 13(16)2021 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439364
6.
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.
Leukemia
; 33(4): 995-1010, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470838
7.
Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients.
Leuk Lymphoma
; 62(5): 1239-1242, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356699